Advanced, Androgen Receptor Positive Triple Negative Breast Cancer

specific

A hormone receptor-positive breast carcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.

Centers

Active Trials

—

Cancer Funding

Top Centers for Advanced, Androgen Receptor Positive Triple Negative Breast Cancer(12)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	—	—	54.2
2	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	—	54.2
3	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive	—	—	54.2
4	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	—	54.2
5	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	54.2
6	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive	—	—	54.2
7	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive	—	—	54.2
8	University of Illinois Cancer CenterChicago, IL	—	—	54.2
9	Boston University Cancer CenterBoston, MA	—	—	54.2
10	Cancer Center at IllinoisUrbana, IL	—	—	54.2
11	University of Cincinnati Cancer CenterCincinnati, OH	—	—	54.2
12	BC CancerVancouver, BC	—	—	54.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →